Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features-Reference-Cited by-同舟云学术

Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features

Published:2013-01-04 Issue:2 Volume:104 Page:266-273
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Matsubara Daisuke,Kishaba Yuka¹,Ishikawa Shumpei²,Sakatani Takashi¹,Oguni Sachiko¹,Tamura Tomoko¹,Hoshino Hiroko¹,Sugiyama Yukihiko³,Endo Shunsuke⁴,Murakami Yoshinori⁵,Aburatani Hiroyuki⁶,Fukayama Masashi²,Niki Toshiro¹

Affiliation:

1. Department of Integrative Pathology; Jichi Medical University; Shimotsuke; Tochigi; Japan

2. Department of Human Pathology; Graduate School of Medicine; The University of Tokyo; Bunkyo-ku; Tokyo; Japan

3. Division of Pulmonary Medicine; Jichi Medical University; Tochigi; Japan

4. Division of General Thoracic Surgery; Jichi Medical University; Shimotsuke; Tochigi; Japan

5. Division of Molecular Pathology; Institute of Medical Science; The University of Tokyo; Minato-ku; Tokyo; Japan

6. Division of Genome Science; Research Center for Advanced Science and Technology; The University of Tokyo; Meguro-ku; Tokyo; Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12065/fullpdf

Reference19 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006

2. Novel therapeutic targets in non-small cell lung cancer;Janku;J Thorac Oncol,2011

3. SWI/SNF nucleosome remodellers and cancer;Wilson;Nat Rev Cancer,2011

4. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma;Jones;Science,2010

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant;Pathology;2024-06

2. Expression patterns of HNF4α, TTF-1, and SMARCA4 in lung adenocarcinomas: impacts on clinicopathological and genetic features;Virchows Archiv;2024-05-06

3. An Autopsy of a Patient with Strongly PD-L1-positive SMARCA4-deficient Large Cell Lung Cancer Treated with Pembrolizumab Who Died of Hyperprogressive Disease;Haigan;2024-02-20

4. Clinicopathological characteristics and treatment outcomes of advanced SMARCA4‐deficient thoracic tumors;Cancer Medicine;2023-12-20

5. The clinicopathological features of BRG1-deficient non-small cell lung cancer and its response to immunotherapy: A single-center retrospective study;Annals of Diagnostic Pathology;2023-12